Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve In terms of Regulation ....
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supriya Lifescience has informed BSE and NSE that its Board of Directors will meet on Wednesday, August 13, 2025. The main item on the agenda is to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2025 (Q1 FY26). The company has also confirmed that the trading window for designated persons and their immediate relatives is closed from July 1, 2025 until 48 hours after the results are declared on August 13. The intimation was filed under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements on August 6, 2025.
This is a routine pre-results announcement with no immediate price impact. Investors should watch for the Q1 FY26 results on August 13 for insights into the company's revenue, margins, and growth trajectory. The closed trading window signals that management is in a sensitive period, as is standard ahead of results.